{
    "nctId": "NCT04638712",
    "briefTitle": "Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients",
    "officialTitle": "Impact of (Neo)Adjuvant Therapy Associating Anthracyclines and Taxanes With or Without Trastuzumab on Skeletal Muscle in Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 13,
    "primaryOutcomeMeasure": "Change in vastus lateralis cross-sectional area",
    "eligibilityCriteria": "Inclusion Criteria:\n\nFor group 1 without trastuzumab :\n\n* Patients must be \u2265 18 years old\n* Patients with breast cancer stage I to III\n* Patients who will receive (neo)adjuvant anthracyclines and weekly taxane, without trastuzumab\n* Patients must have a social security coverage\n* Patients able to speak, read and understand French\n\nFor group 2 with trastuzumab :\n\n* Patients must be \u2265 18 years old\n* Patients with breast cancer grade I to III\n* Patients who will receive (neo)adjuvant anthracyclines and weekly taxane, with trastuzumab\n* Patients must have a social security coverage\n* Patients able to speak, read and understand French\n\nExclusion Criteria:\n\n* History of cancer\n* Previous chemotherapy\n* Patients with known chronic pathology (musculoskeletal disorders, autoimmune, vascular or neuromuscular disease)\n* Pacemaker implantation\n* Contraindication to physical condition evaluation\n* Contraindication to local anesthesia required for microbiopsy\n* Patients \\< 18 years old or patients \u2265 18 years old under guardianship, or supervision\n* Psychiatric, musculoskeletal or neurologic disorders\n* Women that are pregnant or breast-feeding",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}